Acute asthma exacerbations in childhood: Risk factors, prevention and treatment

Expert Review of Respiratory Medicine

Volumn 6, Issue 6, 2012, Pages 629-638

  Guibas, George V ^a   Makris, Michael ^a   Papadopoulos, Nikolaos G ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

asthma; children; definition; exacerbations; phenotypes; prevention; treatment

Indexed keywords

ALLERGEN; AMINOPHYLLINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; HELIOX; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MAGNESIUM SULFATE; MONTELUKAST; OMALIZUMAB; SALBUTAMOL;

ADD ON THERAPY; AIRBORNE PARTICLE; ALLERGIC ASTHMA; ASTHMA; BRONCHODILATATION; CHILD; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EMERGENCY TREATMENT; EXERCISE INDUCED ASTHMA; GASTROESOPHAGEAL REFLUX; HUMAN; LOW DRUG DOSE; MYCOPLASMA PNEUMONIA; PARAMYXOVIRUS INFECTION; PASSIVE SMOKING; PHENOTYPE; RECOMMENDED DRUG DOSE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; VIRUS REPLICATION; WHEEZING;

EID: 84871032362     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.12.68     Document Type: Review

References (114)

1. Moorman JE, Rudd RA, Johnson CA et al.; Centers for Disease Control and Prevention (CDC). National surveillance for asthma -United States, 1980-2004. MMWR. Surveill. Summ. 56(8), 1-54 (2007).
2. Papadopoulos NG, Arakawa H, Carlsen KH et al. International consensus on (ICON) pediatric asthma. Allergy 67(8), 976-997 (2012).
3. Jackson DJ, Sykes A, Mallia P, Johnston SL. Asthma exacerbations: origin, effect, and prevention. J. Allergy Clin. Immunol. 128(6), 1165-1174 (2011).
4. National Heart, Lung, and Blood Institute. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. US Department of Health and Human Services, National Institutes of Health National Heart, Lung, and Blood Institute, Washington, DC, USA (2007).
5. Reddel HK, Taylor DR, Bateman ED et al.; American Thoracic Society/ European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/ European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am. J. Respir. Crit. Care Med. 180(1), 59-99 (2009).
6. 2 LEN-DARE systematic review. Allergy 66(4), 458-468 (2011).
7. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 161(5), 1501-1507 (2000). (Pubitemid 30329018)
8. Jartti T, Lehtinen P, Vuorinen T et al. Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerging Infect. Dis. 10(6), 1095-1101 (2004). (Pubitemid 38697704)
9. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310(6989), 1225-1229 (1995).
10. Khetsuriani N, Kazerouni NN, Erdman DD et al. Prevalence of viral respiratory tract infections in children with asthma. J. Allergy Clin. Immunol. 119(2), 314-321 (2007). (Pubitemid 46204808)
11. Lau SK, Yip CC, Tsoi HW et al. Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J. Clin. Microbiol. 45(11), 3655-3664 (2007). (Pubitemid 350156863)
12. Johnston NW, Johnston SL, Duncan JM et al. The September epidemic of asthma exacerbations in children: a search for etiology. J. Allergy Clin. Immunol. 115(1), 132-138 (2005). (Pubitemid 40075433)
13. Cookson WO, Moffatt MF. Asthma: an epidemic in the absence of infection? Science 275(5296), 41-42 (1997).
14. Ege MJ, Mayer M, Normand AC et al.; GABRIELA Transregio 22 Study Group. Exposure to environmental microorganisms and childhood asthma. N. Engl. J. Med. 364(8), 701-709 (2011).
15. Xepapadaki P, Koutsoumpari I, Papaevagelou V, Karagianni C, Papadopoulos NG. Atypical bacteria and macrolides in asthma. Allergy Asthma. Clin. Immunol. 4(3), 111-116 (2008).
16. Oliver BG, Lim S, Wark P et al. Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Thorax 63(6), 519-525 (2008). (Pubitemid 351831162)
17. Papadopoulos NG, Xepapadaki P, Mallia P et al. Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy 62(5), 457-470 (2007). (Pubitemid 46608365)
18. Heymann PW, Carper HT, Murphy DD et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J. Allergy Clin. Immunol. 114(2), 239-247 (2004). (Pubitemid 39119019)
19. Benoit LA, Holtzman MJ. New immune pathways from chronic post-viral lung disease. Ann. NY Acad. Sci. 1183, 195-210 (2010).
20. Tversky JR, Le TV, Bieneman AP, Chichester KL, Hamilton RG, Schroeder JT. Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-α via Toll-like receptor 9. Clin. Exp. Allergy 38(5), 781-788 (2008). (Pubitemid 351550669)
21. Custovic A. Probability of hospital admission with acute asthma exacerbation increases with increasing specific IgE antibody levels. Allergy Clin. Immunol. Int. J. World Allergy Org. (2007).
22. Murray CS, Poletti G, Kebadze T et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 61(5), 376-382 (2006). (Pubitemid 43723318)
23. Bossios A, Gourgiotis D, Skevaki CL et al. Rhinovirus infection and house dust mite exposure synergize in inducing bronchial epithelial cell interleukin-8 release. Clin. Exp. Allergy 38(10), 1615-1626 (2008).
24. Murray CS, Simpson A, Custovic A. Allergens, viruses, and asthma exacerbations. Proc. Am. Thorac. Soc. 1(2), 99-104 (2004).
25. Jung KH, Hsu SI, Yan B et al. Childhood exposure to fine particulate matter and black carbon and the development of new wheeze between ages 5 and 7 in an urban prospective cohort. Environ. Int. 45, 44-50 (2012).
26. Trasande L, Thurston GD. The role of air pollution in asthma and other pediatric morbidities. J. Allergy Clin. Immunol. 115(4), 689-699 (2005). (Pubitemid 40460841)
27. Bernstein JA, Alexis N, Barnes C et al. Health effects of air pollution. J. Allergy Clin. Immunol. 114(5), 1116-1123 (2004). (Pubitemid 39469153)
28. Chauhan AJ, Inskip HM, Linaker CH et al. Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children. Lancet 361(9373), 1939-1944 (2003). (Pubitemid 36694582)
29. Royal College of Physicians (RCP). Passive smoking and children. A report by the Tobacco Advisory Group. Royal College of Physicians, London (2010).
30. Dong GH, Ren WH, Wang D et al. Exposure to secondhand tobacco smoke enhances respiratory symptoms and responses to animals in 8819 children in kindergarten: results from 25 districts in northeast China. Respiration. 81(3), 179-185 (2011).
31. Rumold R, Jyrala M, Diaz-Sanchez D. Secondhand smoke induces allergic sensitization in mice. J. Immunol. 167(8), 4765-4770 (2001). (Pubitemid 32954359)
32. Quinto KB, Zuraw BL, Poon KY, Chen W, Schatz M, Christiansen SC. The association of obesity and asthma severity and control in children. J. Allergy Clin. Immunol. 128(5), 964-969 (2011).
33. Forno E, Lescher R, Strunk R, Weiss S, Fuhlbrigge A, Celedón JC; Childhood Asthma Management Program Research Group. Decreased response to inhaled steroids in overweight and obese asthmatic children. J. Allergy Clin. Immunol. 127(3), 741-749 (2011).
34. Lugogo NL, Kraft M, Dixon AE. Does obesity produce a distinct asthma phenotype? J. Appl. Physiol. 108(3), 729-734 (2010).
35. Parsons JP, Mastronarde JG. Gastroesophageal reflux disease and asthma. Curr. Opin. Pulm. Med. 16(1), 60-63 (2010).
36. Khoshoo V, Haydel R Jr. Effect of antireflux treatment on asthma exacerbations in nonatopic children. J. Pediatr. Gastroenterol. Nutr. 44(3), 331-335 (2007). (Pubitemid 46673380)
37. McCallister JW, Parsons JP, Mastronarde JG. The relationship between gastroesophageal reflux and asthma: an update. Ther. Adv. Respir. Dis. 5(2), 143-150 (2011).
38. Mireku N, Wang Y, Ager J, Reddy RC, Baptist AP. Changes in weather and the effects on pediatric asthma exacerbations. Ann. Allergy Asthma Immunol. 103(3), 220-224 (2009).
39. Taylor PE, Jonsson H. Thunderstorm asthma. Curr. Allergy Asthma Rep. 4(5), 409-413 (2004). (Pubitemid 39232737)
40. D'Amato G, Liccardi G, D'Amato M, Holgate S. Environmental risk factors and allergic bronchial asthma. Clin. Exp. Allergy 35(9), 1113-1124 (2005).
41. Wu AC, Tantisira K, Li L, Schuemann B, Weiss ST, Fuhlbrigge AL; Childhood Asthma Management Program Research Group. Predictors of symptoms are different from predictors of severe exacerbations from asthma in children. Chest 140(1), 100-107 (2011).
42. Covar RA, Szefler SJ, Zeiger RS et al. Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. J. Allergy Clin. Immunol. 122(4), 741-747.e4 (2008).
43. Forno E, Celedón JC. Predicting asthma exacerbations in children. Curr. Opin. Pulm. Med. 18(1), 63-69 (2012).
44. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or β-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Nonspecific Lung Disease Study Group. Am. Rev. Respir. Dis. 146(3), 547-554 (1992).
45. Martinez FD, Chinchilli VM, Morgan WJ et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet 377(9766), 650-657 (2011).
46. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N. Engl. J. Med. 343, 1054-1063 (2000).
47. Paton J, Jardine E, McNeill E et al. Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone. Arch. Dis. Child. 91(10), 808-813 (2006). (Pubitemid 44521162)
48. Sim D, Griffiths A, Armstrong D, Clarke C, Rodda C, Freezer N. Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma. Eur. Respir. J. 21(4), 633-636 (2003). (Pubitemid 36432517)
49. Bacharier LB, Boner A, Carlsen KH et al.; European Pediatric Asthma Group. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 63(1), 5-34 (2008). (Pubitemid 350198248)
50. Leone FT, Fish JE, Szefler SJ, West SL. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest 124(6), 2329-2340 (2003). (Pubitemid 38010606)
51. Kelly HW, Van Natta ML, Covar RA, Tonascia J, Green RP, Strunk RC; CAMP Research Group. Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the Childhood Asthma Management Program (CAMP) study. Pediatrics 122(1), e53-e61 (2008).
52. Brand PL. Inhaled corticosteroids reduce growth. Or do they? Eur. Respir. J. 17(2), 287-294 (2001). (Pubitemid 32605658)
53. Pedersen S. Do the benefits of daily inhaled steroid treatment of mild asthma outweigh the risks? Arch. Dis. Child. 93(8), 644-645 (2008).
54. Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics 123(3), e519-e525 (2009).
55. Koh MS, Tee A, Lasserson TJ, Irving LB. Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction. Cochrane Database Syst. Rev. 3, CD002739 (2007).
56. Skevaki CL, Christodoulou I, Spyridaki IS et al. Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus. Clin. Exp. Allergy 39(11), 1700-1710 (2009).
57. Edwards MR, Johnson MW, Johnston SL. Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 34(5), 616-624 (2006).
58. Bossley CJ, Saglani S, Kavanagh C et al. Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma. Eur. Respir. J. 34(5), 1052-1059 (2009).
59. Fitzpatrick AM, Gaston BM, Erzurum SC, Teague WG; National Institutes of Health/ National Heart, Lung, and Blood Institute Severe Asthma Research Program. Features of severe asthma in school-age children: atopy and increased exhaled nitric oxide. J. Allergy Clin. Immunol. 118(6), 1218-1225 (2006). (Pubitemid 44854125)
60. Fitzpatrick AM, Teague WG. Severe asthma in children: insights from the national heart, lung, and blood institute's severe asthma research program. Pediatr. Allergy. Immunol. Pulmonol. 23(2), 131-138 (2010).
61. Panickar J, Lakhanpaul M, Lambert PC et al. Oral prednisolone for preschool children with acute virus-induced wheezing. N. Engl. J. Med. 360(4), 329-338 (2009).
62. Bacharier LB, Phillips BR, Bloomberg GR et al.; Childhood Asthma Research and Education Network, National Heart, Lung, and Blood Institute. Severe intermittent wheezing in preschool children: a distinct phenotype. J. Allergy Clin. Immunol. 119(3), 604-610 (2007).
63. Zeiger RS, Mauger D, Bacharier LB et al.; CARE Network of the National Heart, Lung, and Blood Institute. Daily or intermittent budesonide in preschool children with recurrent wheezing. N. Engl. J. Med. 365(21), 1990-2001 (2011).
64. Wells KE, Peterson EL, Ahmedani BK, Severson RK, Gleason-Comstock J, Williams LK. The relationship between combination inhaled corticosteroid and long-acting b-agonist use and severe asthma exacerbations in a diverse population. J. Allergy Clin. Immunol. 129(5), 1274.e2-1279.e2 (2012).
65. Bisgaard H, Le Roux P, Bjåmer D, Dymek A, Vermeulen JH, Hultquist C. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest 130(6), 1733-1743 (2006). (Pubitemid 46033427)
66. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting β-agonists on severe asthma exacerbations and asthma-related deaths. Ann. Intern. Med. 144(12), 904-912 (2006). (Pubitemid 46768131)
67. Bisgaard H, Zielen S, Garcia-Garcia ML et al. Montelukast reduces asthma exacerbations in 2-to 5-year-old children with intermittent asthma. Am. J. Respir. Crit. Care Med. 171(4), 315-322 (2005). (Pubitemid 40223397)
68. Robertson CF, Price D, Henry R et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 175(4), 323-329 (2007).
69. Johnston NW, Mandhane PJ, Dai J et al. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. Pediatrics 120(3), e.702-e.712 (2007). (Pubitemid 47358285)
70. Grzelewski T, Stelmach I. Exercise-induced bronchoconstriction in asthmatic children: a comparative systematic review of the available treatment options. Drugs 69(12), 1533-1553 (2009).
71. Castro-Rodriguez JA, Rodrigo GJ. The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis. Arch. Dis. Child. 95(5), 365-370 (2010).
72. Szefler SJ, Phillips BR, Martinez FD et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J. Allergy Clin. Immunol. 115(2), 233-242 (2005). (Pubitemid 40215084)
73. Busse WW, Morgan WJ, Gergen PJ et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N. Engl. J. Med. 364(11), 1005-1015 (2011).
74. Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst. Rev. 8, CD001186 (2010).
75. Jang YJ, Kwon HJ, Lee BJ. Effect of clarithromycin on rhinovirus-16 infection in A549 cells. Eur. Respir. J. 27(1), 12-19 (2006). (Pubitemid 43092661)
76. Koutsoubari I, Papaevangelou V, Konstantinou GN et al. Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study. Pediatr. Allergy Immunol. 23(4), 385-390 (2012).
77. Belessis Y, Dixon S, Thomsen A et al. Risk factors for an intensive care unit admission in children with asthma. Pediatr. Pulmonol. 37(3), 201-209 (2004). (Pubitemid 38326369)
78. Lyell PJ, Villanueva E, Burton D, Freezer NJ, Bardin PG. Risk factors for intensive care in children with acute asthma. Respirology 10(4), 436-441 (2005). (Pubitemid 43942611)
79. van den Bosch GE, Merkus PJ, Buysse CM et al. Risk factors for pediatric intensive care admission in children with acute asthma. Respir. Care 57(9), 1391-1397 (2012).
80. Zeiger RS, Dawson C, Weiss S. Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP). J. Allergy Clin. Immunol. 103(3 Pt 1), 376-387 (1999). (Pubitemid 29136289)
81. Gorelick M, Scribano PV, Stevens MW, Schultz T, Shults J. Predicting need for hospitalization in acute pediatric asthma. Pediatr. Emerg. Care 24(11), 735-744 (2008).
82. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for β-agonist treatment of acute asthma. Cochrane Database Syst. Rev. 2, CD000052 (2006).
83. Boyd R, Stuart P. Pressurised metered dose inhalers with spacers versus nebulisers for β-agonist delivery in acute asthma in children in the emergency department. Emerg. Med. J. 22(9), 641-642 (2005). (Pubitemid 41200631)
84. Staggs L, Peek M, Southard G et al. Evaluating the length of stay and value of time in a pediatric emergency department with two models by comparing two different albuterol delivery systems. J. Med. Econ. 15(4), 704-711 (2012).
85. Arnold DH, Moore PE, Abramo TJ, Hartert TV. The dilemma of albuterol dosing for acute asthma exacerbations in pediatric patients. Chest 139(2), 472 (2011).
86. Karpel JP, Aldrich TK, Prezant DJ, Guguchev K, Gaitan-Salas A, Pathiparti R. Emergency treatment of acute asthma with albuterol metered-dose inhaler plus holding chamber: how often should treatments be administered? Chest 112(2), 348-356 (1997). (Pubitemid 27349423)
87. Schuh S, Reisman J, Alshehri M et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N. Engl. J. Med. 343(10), 689-694 (2000).
88. Nakanishi AK, Klasner AK, Rubin BK. A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children. Chest 124(3), 790-794 (2003). (Pubitemid 37123291)
89. Edmonds ML, Camargo CA Jr, Pollack CV Jr, Rowe BH. The effectiveness of inhaled corticosteroids in the emergency department treatment of acute asthma: a meta-analysis. Ann. Emerg. Med. 40(2), 145-154 (2002). (Pubitemid 34815889)
90. Scarfone RJ, Loiselle JM, Wiley JF 2nd, Decker JM, Henretig FM, Joffe MD. Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children. Ann. Emerg. Med. 26(4), 480-486 (1995).
91. Sekerel BE, Sackesen C, Tuncer A, Adalioglu G. The effect of nebulized budesonide treatment in children with mild to moderate exacerbations of asthma. Acta Paediatr. 94(10), 1372-1377 (2005). (Pubitemid 41510644)
92. Devidayal, Singhi S, Kumar L, Jayshree M. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta Paediatr 88(8), 835-840 (1999). (Pubitemid 29439604)
93. Rodrigo G, Rodrigo C. Inhaled flunisolide for acute severe asthma. Am. J. Respir. Crit. Care Med. 157(3 Pt 1), 698-703 (1998).
94. Manjra AI, Price J, Lenney W, Hughes S, Barnacle H. Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respir. Med. 94(12), 1206-1214 (2000). (Pubitemid 32049248)
95. Volovitz B, Bentur L, Finkelstein Y et al. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J. Allergy Clin. Immunol. 102(4 Pt 1), 605-609 (1998).
96. Nuhoglu Y, Bahçeciler NN, Barlan IB, Müjdat Basaran M. The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children. Ann. Allergy Asthma Immunol. 86(3), 318-322 (2001). (Pubitemid 32240218)
97. Schuh S, Dick PT, Stephens D et al. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma. Pediatrics 118(2), 644-650 (2006). (Pubitemid 46085422)
98. Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and β2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst. Rev. 4, CD000060 (2000).
99. Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 60(9), 740-746 (2005). (Pubitemid 41297893)
100. Jones LA, Goodacre S. Magnesium sulphate in the treatment of acute asthma: evaluation of current practice in adult emergency departments. Emerg. Med. J. 26(11), 783-785 (2009).
101. Cheuk DK, Chau TC, Lee SL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch. Dis. Child. 90(1), 74-77 (2005). (Pubitemid 40052260)
102. Torres S, Sticco N, Bosch JJ et al. Effectiveness of magnesium sulfate as initial treatment of acute severe asthma in children, conducted in a tertiary-level university hospital: a randomized, controlled trial. Arch. Argent. Pediatr. 110(4), 291-296 (2012).
103. Ciarallo L, Brousseau D, Reinert S. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Arch. Pediatr. Adolesc. Med. 154(10), 979-983 (2000).
104. Mohammed S, Goodacre S. Intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-analysis. Emerg. Med. J. 24(12), 823-830 (2007). (Pubitemid 350200629)
105. Gupta VK, Cheifetz IM. Heliox administration in the pediatric intensive care unit: an evidence-based review. Pediatr. Crit. Care Med. 6(2), 204-211 (2005). (Pubitemid 40724315)
106. Habib DM, Garner SS, Brandeburg S. Effect of helium-oxygen on delivery of albuterol in a pediatric, volume-cycled, ventilated lung model. Pharmacotherapy 19(2), 143-149 (1999). (Pubitemid 29072025)
107. Kim IK, Phrampus E, Venkataraman S et al. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics 116(5), 1127-1133 (2005). (Pubitemid 46056418)
108. Rivera ML, Kim TY, Stewart GM, Minasyan L, Brown L. Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: a blinded, randomized controlled trial. Am. J. Emerg. Med. 24(1), 38-42 (2006). (Pubitemid 41773192)
109. Martinón-Torres F. Noninvasive ventilation with helium-oxygen in children. J. Crit. Care 27(2), 220.e1-220.e9 (2012).
110. Bigham MT, Jacobs BR, Monaco MA et al. Helium/oxygen-driven albuterol nebulization in the management of children with status asthmaticus: a randomized, placebo-controlled trial. Pediatr. Crit. Care Med. 11(3), 356-361 (2010).
111. Wheeler DS, Jacobs BR, Kenreigh CA, Bean JA, Hutson TK, Brilli RJ. Theophylline versus terbutaline in treating critically ill children with status asthmaticus: a prospective, randomized, controlled trial. Pediatr. Crit. Care Med. 6(2), 142-147 (2005). (Pubitemid 40724305)
112. Ream RS, Loftis LL, Albers GM, Becker BA, Lynch RE, Mink RB. Efficacy of IV theophylline in children with severe status asthmaticus. Chest 119(5), 1480-1488 (2001). (Pubitemid 32686033)
113. Roberts G, Newsom D, Gomez K et al.; North West Thames Asthma Study Group. Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial. Thorax 58(4), 306-310 (2003). (Pubitemid 36411415)
114. Mitra A, Bassler D, Goodman K, Lasserson TJ, Ducharme FM. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. Cochrane Database Syst. Rev. 2, CD001276 (2005).